, and prediabetic mice (HFD 1 week), 2 hours post-gavage with 10 9 cfu of GFP-E. coli. (mean ± SEM; n = 8; data with identical superscript letters do not differ from each other with p> 0.05). E. Number of GFP-E. coli cfu per g of MAT in wild-type (WT), ob/ob, ob/obxCD14 -/-, and CD14 -/mice (all NC-fed), 2 hours post-gavage with 10 9 cfu of GFP-E. coli. (mean ± SEM; n = 8 to 10; data with identical superscript letters do not differ from each other with p> 0.05). Figure S5 . A probiotic treatment with Bifidobacterium lactis 420 (B420) reverses high-fat diet (HFD)-induced mucosal dysbiosis, tissue inflammation, glucose intolerance and fasted hyperinsulinemia. A. Experimental design for the treatment of HFD-induced diabetic mice with B420. Briefly, wild-type mice (WT) were fed a HFD for 4 weeks, then randomized and treated daily with the probiotic Bifidobacterium animalis subsp. lactis 420 (B420, DSM 22089, 10 9 cfu/day, Danisco) or the vehicle, for 4 weeks. B. Concentration of Bifidobacterium spp. in ileal mucus quantified by qPCR (log cells/g of mucus). (mean ± SEM; n = 8; data with identical superscript letters do not differ with p> 0.05). C, D. Concentration of mRNA coding for the inflammatory markers TNF-α, IL-1β, PAI-1, and IL-6 in liver (C), and muscle (D), as quantified by RT-qPCR. (mean ± SEM; n = 8 to 10; data with identical superscript letters do not differ with p> 0.05; cytokines expression were not compared between themselves). E. Intraperitoneal glucose tolerance test (IPGTT; 1 g/kg). (mean ± SEM; n = 8; *: p<0.05 vs HFD + vehicle). F. Fasted plasma insulin (µU/mL). (mean ± SEM; n = 8 to 10; data with identical superscript letters do not differ with p> 0.05).
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Animals and diets
Mice were from Charles River (C57bl6, ob/ob, CD14 -/-), from our colony as previously described (Cani et al, 2008 ) (ob/obxCD14 -/-), from CNRS UMR6218 (Orléans, France) (Myd88 -/-) or from INSERM U389 (Paris, France) (Nod1 -/-, Nod2 -/-). They were fed with either a normal chow diet (NC) or a high-fat diet (HFD) (Safe, Augy, France), previously demonstrated to generate fasting hyperglycemia, glucose intolerance, and insulin resistance following one month of feeding (Burcelin et al, 2002; Riant et al, 2009 ). The diabetic phenotype was assessed by intraperitoneal or oral glucose tolerance tests, and fat mass quantified with the EchoMRI 3-in-1 Composition Analyzer (Echo Medical Systems, Houston, Texas, USA). All of the animal experimental procedures were validated by the local ethical committee of the Rangueil Hospital.
Microscopic visualization and quantification of GFP-E. coli in ileal mucosa
Two or five hours after gavage with 10 9 GFP-E. coli, ileal mucosa was scrapped off, spread onto glass slides and observed by fluorescence microscopy for image acquisition (Microscope Zeiss Axio Observer Z1 with AxioVision 4.7.2 acquisition software, Carl Zeiss MicroImaging GmbH, Germany). GFP-E. coli were enumerated in 10 different fields per mouse.
Histological localization of GFP-E. coli in ileum
Two or five hours after gavage with 10 9 GFP-E. coli, a piece of ileum was formalin-fixed and frozen. Cryostat sections (8µm) were counterstained with 4,6-diamidino-2-phenylindole (200 ng/mL, Sigma-Aldrich, France), mounted and observed by fluorescence microscopy (Zeiss Axio Observer Z1, Carl Zeiss MicroImaging GmbH, Germany). Images were collected using a Zeiss AxioCam MRm digital camera and AxioVision 4.7.2 acquisition software (Carl Zeiss MicroImaging GmbH, Germany), and merged with Adobe Photoshop CS3 Extended 10.0 (Adobe Systems Inc., California, USA). Transmucosal GFP-E. coli, i.e. not localized in the lumen, were enumerated in 10 different fields per mouse.
Immunodetection of dendritic cells in ileum and mesenteric lymph nodes
Two hours after gavage with 10 9 GFP-E. coli, mesenteric lymph nodes (MLN) and a segment of ileum were formalin-fixed and frozen. Cryostat sections (8µm) were incubated with hamster anti-mouse CD11c as primary antibody (clone HL3; BD Biosciences Pharmingen, California, USA; 1/1,000, overnight, room temperature), biotin mouse anti-hamster IgG as secondary antibody (BD Biosciences Pharmingen, California, USA; 1/1,000, 1h 30 min, room temperature), then with Texas Red dye-conjugated streptavidin (Jackson ImmunoResearch Laboratories, Pennsylvania, USA, 1/1,000, 30 min in the dark at room temperature) and finally counterstained with 4,6-diamidino-2-phenylindole (200 ng/mL, Sigma-Aldrich, France). Slides were then observed by using a Zeiss Axio Observer Z1 fluorescence microscope (Carl Zeiss MicroImaging GmbH, Germany). Images were collected by using a Zeiss AxioCam MRm digital camera and AxioVision 4.7.2 acquisition software (Carl Zeiss MicroImaging GmbH, Germany) and merged with Adobe Photoshop CS3 Extended 10.0 (Adobe Systems Inc., California, USA). GFP-E. coli appear in green, cell nuclei in blue, and CD11c-positive cells in red. CD11c-positive cells co-localized with GFP-E. coli are yellow. CD11c-positive cells co-localized with GFP-E. coli in ileum and MLN, were enumerated in 10 different fields per mouse.
Quantification of GFP-E. coli in blood by RT-qPCR
Blood was collected from the inferior vena cava 2 hours after gavage with 10 9 GFP-E. coli. Blood cells were first mechanically disrupted by mini-beads vibrating at 30 hertz for 2 x 3 min on a Retsch Tissue Lyser II (Qiagen GmbH, Germany) with 200 mg of acid-washed glass beads (Ø < 106 µm; Sigma-Aldrich, France) in Tripure isolation reagent before total mRNAs were extracted according to manufacturer's procedure (Roche Applied Science, Germany). Contaminating DNA was eliminated by DNase I (RNase-free, Ambion Ltd, UK) and the DNase I was removed by a second phenol/chloroform extraction with Tripure, prior to reverse transcription using eAMV-RT (Sigma-Aldrich, France). Primers specific for GFP were designed for this study and were as follows: GFP forward, 5'-CTACCTGTTCCATGGCCAAC-3'; GFP reverse: 5'-AGGGTATCACCTTCAAACTTGACT-3'. The qPCR assay was performed from the cDNAs with a Stepone Plus Real-Time PCR System and Power SYBR Green PCR Master Mix (Applied Biosystems, California, USA). Data were analyzed by absolute quantification using a standard curve of cDNA synthesized from RNA obtained from a pure culture of GFP-E. coli, in order to express the results as cfu-equivalent/mL blood.
Quantification of bacterial DNA in intestine, blood and mesenteric adipose tissue by qPCR
Genomic DNA was isolated from blood, mesenteric adipose tissue (MAT), mesenteric lymph nodes (MLN) or intestine (contents and mucosa), using Tripure isolation reagent (Roche Applied Science, Germany). Briefly, tissues were first homogenized in Tripure and then the cells were mechanically disrupted by mini-beads vibrating at 30 hertz for 2 x 3 min on a Retsch Tissue Lyser II (Qiagen GmbH, Germany) with 200 mg of acid-washed glass beads (Ø < 106 µm; Sigma-Aldrich, France), before DNA was extracted according to manufacturer's procedure (Roche Applied Science, Germany). Total bacterial DNA was quantified using the following 16S rRNA universal primers: EUBAC-F, 5'-TCCTACGGGAGGCAGCAGT-3'; EUBAC-R, 5'-GGACTACCAGGGTATCTAATCCTGTT-3' (Nadkarni et al, 2002) . E. coli DNA was quantified using the following 16S-23S rRNA primers: IEC-F, 5'-CAATTTTCGTGTCCCCTTCG-3'; IEC-R, 5'-GTTAATGATAGTGTGTCGAAAC-3' (Khan et al, 2007) . To quantify all gram-negative bacteria, primers targeting the Lipid A disaccharide synthase (LpxB) gene were designed and were as follows: LpxB-F, 5'-GAAGCNTGGTANGANATGGAAG-3' with N6 (degenerated nucleotide in 6 th position from 5') = 90%C + 10%T, N12 = 60%C + 40%T and N15 = 60%A + 40%G; LpxB-R, 5'-GGNGCNTCNATNCCNACNAANACATCNGG-3' with N3 = 50%C + 50%G, N6 = 70%C + 30%T, N9 = 90%A + 10%G, N12 = 50%A + 15%C + 35%T, N15 = 60%A + 10%C + 30%G, N18 = 90%A + 10%G, N21 = 45%A + 10%C +45%G and N27 = 10%A + 10%C + 40%G + 40%T. These LpxB primers were validated for their ability to produce the expected PCR product. To this aim, based upon the E. coli LpxB gene sequence (Crowell et al, 1987) , non-degenerated primers where designed, used with E. coli DNA in a final point PCR reaction and the PCR product was visualized on 6% acrylamide gel after ethidium bromide (EtBr) staining. Quantitative PCR for total bacteria, E. coli and gram-negative bacteria were carried out with a Power SYBR Green PCR Master Mix and Stepone Plus Real-Time PCR System (Applied Biosystems, California, USA). Data were analyzed by absolute quantification using DNA standard curves obtained from a pure culture of E. coli.
Quantification of bacterial RNA in mesenteric adipose tissue by RT-qPCR
Mesenteric adipose tissue (MAT) samples were processed for mRNAs extraction as described for blood, with additional homogenization in Tripure isolation reagent with Ultra-Turrax before cells disrupting by mini-beads vibrating. Contaminating DNA was eliminated by DNase I (RNase-free, Ambion Ltd, UK) and DNase I was removed by a second phenol/chloroform extraction with Tripure, prior to reverse transcription using eAMV-RT (Sigma-Aldrich, France). Total bacterial RNA was quantified from synthesized cDNAs, using EUBAC 16S rRNA universal primers already described above for total bacterial DNA quantification. Data were analyzed by absolute quantification using a standard curve of cDNA synthesized from RNA obtained from a pure culture of GFP-E. coli.
Denaturing gradient gel electrophoresis (DGGE) of bacteria in caecum, blood and mesenteric adipose tissue
Genomic DNA was isolated from caecal contents, blood, or mesenteric adipose tissue (MAT), using Tripure isolation reagent (Roche Applied Science, Germany) as described above for bacterial DNA quantification by qPCR in the same tissues. The variable V3 region of the 16S rRNA gene was amplified by final point PCR with primers amplifying the conserved V3 surrounding region. The nucleotide sequences of the primers are as follows: HDA1-GC, 5'-CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCACGGGGGGCCTACGGGAGGCAGCAG-3' (GC clamp in bold); HDA-2, 5'-ATTACCGCGGCTGCTGG-3'. PCR amplification was done with the thermal cycler VWR Unocycler (VWR International, Belgium). The samples were first incubated for 5 min at 94°C to denature the DNA template and subsequently cooled down to 80°C, at which point 0.35 U of Taq DNA polymerase (Sigma-Aldrich, Saint-Louis, USA) was added: this hot start technique minimizes non-specific annealing of primers to non-target DNA. Twenty cycles were then carried out as follows: 94°C for 30 sec, annealing for 45 sec and 72°C for 1 min. The annealing temperature started 10°C above the expected annealing temperature and was decreased by 1°C every second cycle until a touchdown at 55°C, this procedure reducing the formation of spurious by-products during the amplification process. Ten more cycles were then carried out at 55°C as annealing temperature and the final primer extension was carried out at 72°C for 30 min. Amplification products were first analyzed by electrophoresis in 6% acrylamide gels and EtBr staining to check for the presence of the 233bp expected product. DGGE was performed with a DGGE-2401 system (CBS Scientific Company, California, USA). Electrophoresis was carried out with 0.75mm-thick 8% polyacrylamide gels (ratio of acrylamide to bisacrylamide, 37.5:1) submerged in TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA; pH 7.4) at 60°C. The electrophoresis was run for 16 h at 60 V in a linear 35 to 55% denaturing gradient with 100% denaturant defined as 7 M urea and 40% deionized formamide. The gels were stained for 1 h in TAE buffer with Sybr Safe DNA gel stain (Invitrogen, Eugène, USA), visualized by using a Typhoon 9400 variable mode imager fluorescent scanner and analyzed with ImageQuant TL software (v2003; Amersham Biosciences, Little Chalfont, England).
Quantification of bacterial groups in mesenteric adipose tissue and ileal mucosa by qPCR
Bacterial DNA was extracted from mesenteric adipose tissue (MAT) and ileal mucosa by first disrupting tissues and cells by milling with ceramic (ø 1.4 mm) and glass beads (ø 0.1 mm) (6800 rpm, 3 × 30 s; Precellys 24, Bertin Technologies, Montigny, France), followed by extraction and purification of DNA with the QIAamp Stool kit (Qiagen, Leiden, The Netherlands) according to manufacturer's instructions. Quantitative real-time PCR (Applied Biosystems Fast 7500; Foster City, CA, USA) was used to quantify Bacteroides-Prevotella-Porphyromonas group (Rinttila et al, 2004) , genus Enterococcus (Rinttila et al, 2004) , Enterobacteriaceae group (Matsuda et al, 2007) and genus Lactobacillus (Makivuokko et al, 2005) from MAT and the genus Bifidobacterium (Makivuokko et al, 2005) from ileal mucus as previously described.
Surgical procedures, infusions, and isotope measurements
Insulin sensitivity was assessed by the euglycemic-hyperinsulinemic clamp method as already described (Riant et al, 2009 ). Briefly, 6h-fasted mice, indwelled with an intrafemoral catheter, were infused with insulin at a rate of 18 mU.kg -1 .min -1 for 3 hours. For glucose turnover measurements, D-( 3 H)3-glucose (Perkin-Elmer, Boston, MA) was simultaneously infused at a rate of 30 µCi.kg -1 . D-( 3 H)3-glucose enrichments were determined from total blood after deproteinization by a Zn(OH) 2 precipitation (Riant et al, 2009 ).
Fasted plasma insulin concentration
Plasma insulin concentrations were determined using an enzyme-linked immunosorbent assay (ELISA) kit (Mercodia, Upssala, Sweden) at completion of the fasting period (6 h) in 10 µL of plasma collected from tail blood.
Quantification of pro-inflammatory markers expression by RT-qPCR
Total RNAs from liver, muscle (vast lateralis) and mesenteric adipose tissue (MAT) were prepared using the Tripure isolation reagent (Roche Applied Science, Germany). cDNA was synthesized using a high capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, California, USA) and qPCRs were carried out with a Stepone Plus Real-Time PCR System and Power SYBR Green PCR Master Mix (Applied Biosystems, California, USA). Primer sequences for the targeted mouse genes were the following: forward tumor necrosis factor-α (TNF-α), 5'-CATCTTCTCAAAATTCGAGTGACAA-3'; reverse TNF-α, 5'-TGGGAGTAGACAAGGTACAACCC-3'; forward interleukin-1β (IL-1β), 5'-TCGCTCAGGGTCACAAGAAA-3'; reverse IL-1β, 5'-CATCAGAGGCAAGGAGGAAAAC-3'; forward plasminogen activator inhibitor 1 (PAI-1), 5'-ACAGCCTTTGTCATCTCAGCC-3'; reverse PAI-1, 5'-CCGAACCACAAAGAGAAAGGA-3'; forward interferon-γ (IFN-γ), 5'-TTGGCTTTGCAGCTCTTCCT-3'; reverse IFN-γ, 5'-TGACTGTGCCGTGGCAGTA-3'; forward interleukin-6 (IL-6), 5'-ACAAGTCGGAGGCTTAATTACACAT-3'; reverse IL-6, 5'-TTGCCATTGCACAACTCTTTTC-3'; forward ribosomal protein L19 (RPL19), 5'-GAAGGTCAAAGGGAATGTGTTCA-3'; reverse RPL19, 5'-CCTTGTCTGCCTTCAGCTTGT-3'. The relative amount of each mRNA studied was normalized to RPL19 rRNA levels as housekeeping gene, and the data were analyzed according to the 2 -Δ∆Ct method.
